Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical Journal

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ20020348PMID 11982483PMCID PMC1222725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgically confirmed myelographic classification of congenital intraspinal lipoma in the lumbosacral region

  2004cited by this paper
• Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.

  2001cited by this paper
• Vasopressin-stimulated Ca2+ spiking in vascular smooth muscle cells involves phospholipase D.

  2001cited by this paper
• Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.

  2001cited by this paper
• Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.

  2001cited by this paper
• Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1‐phosphate

  2000cited by this paper
• Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species

  2000cited by this paper
• Characterization of plasma unsaturated lysophosphatidylcholines in human and rat.

  2000cited by this paper
• Functions of a new family of sphingosine-1-phosphate receptors.

  2000cited by this paper
• Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.

  1999cited by this paper
• Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor

  1999cited by this paper
• Lysophospholipid receptors: implications for neural signaling.

  1999cited by this paper
• Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

  1999cited by this paper
• Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells.

  1999cited by this paper
• Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of In vitro fertilization patients.

  1999cited by this paper
• Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction.

  1999cited by this paper
• Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma.

  1999cited by this paper
• Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid*

  1999cited by this paper
• Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats.

  1999cited by this paper
• Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate

  1998cited by this paper
• Characterization of a receptor subtype-selective lysophosphatidic acid mimetic.

  1998cited by this paper
• Growth factor-like phospholipids generated after corneal injury.

  1998cited by this paper
• Growth factor-like phospholipids generated after corneal injury.

  1998cited by this paper
• Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis

  1997cited by this paper
• Lysophosphatidic Acid Increases Tight Junction Permeability in Cultured Brain Endothelial Cells

  1997cited by this paper
• Dietary fatty acids--the N-6/N-3 balance and chronic elderly diseases. Excess linoleic acid and relative N-3 deficiency syndrome seen in Japan.

  1996cited by this paper
• Regulation by IL-5 of expression of functional platelet-activating factor receptors on human eosinophils.

  1996cited by this paper
• N-palmitoyl-serine and N-palmitoyl-tyrosine phosphoric acids are selective competitive antagonists of the lysophosphatidic acid receptors.

  1996cited by this paper
• A family of phospholipid autacoids: occurrence, metabolism and bioactions.

  1995cited by this paper
• Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis.

  1995cited by this paper
• Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta.

  1994cited by this paper
• Lysophosphatidylcholine from white muscle of bonito Euthynnus pelamis (Linnaeus): involvement of phospholipase A1 activity for its production.

  1994cited by this paper
• Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator.

  1994cited by this paper
• Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor.

  1994cited by this paper
• The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin.

  1994cited by this paper
• The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

  1993cited by this paper
• Unsaturated Fatty Acids Esterified in 2‐Acyl‐1‐Lysophosphatidylcholine Bound to Albumin Are More Efficiently Taken up by the Young Rat Brain than the Unesterified Form

  1992cited by this paper
• Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells.

  1992cited by this paper
• The human platelet as a reproducible and sensitive cell for the detection and assay of platelet-activating factor.

  1992cited by this paper
• Role of oxidized low density lipoprotein in atherogenesis.

  1991cited by this paper
• Quantification, characterization and fatty acid composition of lysophosphatidic acid in different rat tissues

  1989cited by this paper
• Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin.

  1989cited by this paper
• Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.

  1987cited by this paper
• Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma.

  1986cited by this paper
• Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine.

  1986cited by this paper
• Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma.

  1986cited by this paper
• Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor.

  1985cited by this paper
• Effects of lysophosphatidic acids and their structural analogs on arterial blood pressure of cats.

  1985cited by this paper
• Analyses of lysophosphatidic acids by gas chromatography mass spectrometry without hydrolytic pretreatment.

  1984cited by this paper
• Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators?

  1982cited by this paper
• Acyl and phosphoryl migration in lysophospholipids: importance in phospholipid synthesis and phospholipase specificity.

  1982cited by this paper
• Phosphatidylcholine formation from exogenous lysophosphatidylcholine in isolated hamster heart.

  1982cited by this paper
• Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship.

  1981cited by this paper
• Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.

  1979cited by this paper
• Platelet Aggregation Evoked In Vitro and In Vivo by Phosphatidic Acids and Lysoderivatives: Identity with Substances in Aged Serum (DAS)

  1979cited by this paper
• Metabolism of lysolecithin in vivo and in vitro with particular emphasis on the arterial wall.

  1974cited by this paper
• The uptake and metabolism of plasma lysophosphatidylcholine in vivo by the brain of squirrel monkeys.

  1972cited by this paper
• Determination of lipid phosphorus in the nanomolar range.

  1970cited by this paper
• Synthesis of fatty acid anhydrides by reaction with dicyclohexylcarbodiimide.

  1966cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper

• Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer.

  2023cites this paper
• Autotaxin facilitates selective LPA receptor signaling

  2022cites this paper
• Interplay between LPA2 and LPA3 in LPA-mediated phosphatidylserine cell surface exposure and extracellular vesicles release by erythrocytes.

  2021cites this paper
• Bioactive Ether Lipids: Primordial Modulators of Cellular Signaling

  2021cites this paper
• Regulation of Tumor Immunity by Lysophosphatidic Acid

  2020cites this paper
• Lysolipid Chain Length Switches Agonistic to Antagonistic G Protein-Coupled Receptor Modulation.

  2020cites this paper
• Distinct contributions of two choline-producing enzymatic activities to lysophosphatidic acid production in human amniotic fluid from pregnant women in the second trimester and after parturition.

  2020cites this paper
• A low level of lysophosphatidic acid in human gingival crevicular fluid from patients with periodontitis due to high soluble lysophospholipase activity: Its potential protective role on alveolar bone loss by periodontitis.

  2020cites this paper
• 1-O-alkyl glycerophosphate-induced CD36 expression drives oxidative stress in microglial cells.

  2019cites this paper
• Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.

  2019cites this paper
• Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis.

  2019cites this paper
• Platelets, autotaxin and lysophosphatidic acid signalling: win‐win factors for cancer metastasis

  2018cites this paper
• Role of lysophosphatidic acid receptors in spinal cord injury physiopathology

  2017cites this paper
• Forty five years with membrane phospholipids, phospholipases and lipid mediators: A historical perspective.

  2016cites this paper
• Preferable existence of polyunsaturated lysophosphatidic acids in human follicular fluid from patients programmed with in vitro fertilization.

  2016cites this paper
• A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay[S]

  2016cites this paper
• Modulation of Hexadecyl‐LPA‐Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5

  2016cites this paper
• Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.

  2016cites this paper
• Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome

  2015cites this paper
• Lysophospholipids: Advances in Synthesis and Biological Significance

  2015cites this paper
• Development and application of proteomic tools to study platelet function in the context of cardiovascular disease

  2014cites this paper
• New Members of the Mammalian Glycerophosphodiester Phosphodiesterase Family

  2014cites this paper
• Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis

  2014cites this paper
• Characterisation of human airway smooth muscle cell lysophosphatidic acid receptors in asthma and health

  2014cites this paper
• Targeting Platelet G Protein‐Coupled Receptors for Antithrombotic Therapy

  2013cites this paper
• LPA Receptor Subtypes LPA1 and LPA2 as Potential Drug Targets

  2013cites this paper
• Current progress in non-Edg family LPA receptor research.

  2013cites this paper
• Characterization of human vascular smooth muscle cells from atherosclerotic and non-atherosclerotic carotid artery

  2013cites this paper
• Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation[S]

  2013cites this paper
• Selective non-lipid modulator of LPA5 activity in human platelets.

  2012cites this paper
• Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome.

  2012cites this paper
• Lysophosphatidic acid in atherosclerotic diseases

  2012influential citation
• Biosynthesis of alkyl lysophosphatidic acid by diacylglycerol kinases.

  2012cites this paper
• Lysophosphatidic acid effects on atherosclerosis and thrombosis.

  2011cites this paper
• Oral Administration of 2-Docosahexaenoyl Lysophosphatidylcholine Displayed Anti-Inflammatory Effects on Zymosan A-Induced Peritonitis

  2011cites this paper
• 2-Polyunsaturated Acyl Lysophosphatidylethanolamine Attenuates Inflammatory Response in Zymosan A-Induced Peritonitis in Mice

  2011cites this paper
• Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

  2011cites this paper
• Non-Edg family LPA receptors: the cutting edge of LPA research.

  2011cites this paper
• Lysophosphatidic acid production and signaling in platelets

  2011cites this paper
• Lysophosphatidic acid effects on atherosclerosis and thrombosis

  2011cites this paper
• Aiming drug discovery at lysophosphatidic acid targets

  2010cites this paper
• Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis

  2009cites this paper
• Inhibition of lysophospholipase D activity by fish egg extracts

  2009cites this paper
• Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6*

  2009cites this paper
• Prostaglandins and Other Lipid Mediators eview on-Edg family lysophosphatidic acid ( LPA ) receptors

  2009cites this paper
• Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis*

  2009cites this paper
• P 2 Y 5 is a G i , G 12 / 13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion

  2009cites this paper
• P2Y5 is a G(alpha)i, G(alpha)12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesion.

  2009cites this paper
• Non-Edg family lysophosphatidic acid (LPA) receptors.

  2009cites this paper
• Cyclic phosphatidic acid - a unique bioactive phospholipid.

  2008cites this paper
• Individual Heterogeneity in Platelet Response to Lysophosphatidic Acid: Evidence for a Novel Inhibitory Pathway

  2008cites this paper
• Lysophospholipid signaling: beyond the EDGs.

  2008cites this paper
• Structural Importance of the Acyl Group in Substrate Specificity of Purified Bovine Lysophospholipase D

  2008cites this paper
• Organophosphorus compounds: intervention in mechanisms of signal transduction relevant to proliferative, immunological and circulatory disorders.

  2008cites this paper
• Lysophosphatidic acid-induced platelet shape change revealed through LPA1–5 receptor-selective probes and albumin

  2008cites this paper
• The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid.

  2008cites this paper
• Roles of lysophosphatidic acid in cardiovascular physiology and disease.

  2008cites this paper
• The regulation of cellular trafficking of the human lysophosphatidic acid receptor 1: Identification of the molecular determinants required for receptor trafficking

  2007cites this paper
• Production of bioactive lysophosphatidic acid by lysophospholipase D in hen egg white.

  2007cites this paper
• Mechanism of F-actin crosslinking by filamin A and the anti-inflammatory functions of plasma gelsolin in bodily fluids

  2007cites this paper
• Lysophospholipids: two-faced mediators in atherosclerosis

  2007cites this paper
• Untersuchungen zur Rolle von Lysophosphatidsäure als Thrombozyten-aktivierende Substanz arteriosklerotischer Gefäßläsionen

  2006cites this paper
• [Phosphodiesterases that extracellularly produces a lysolipid mediator].

  2006cites this paper
• Molecular Defects in the ABCA1 Pathway Affect Platelet Function

  2006cites this paper
• Platelet Interaction with Bioactive Lipids Formed by Mild Oxidation of Low-Density Lipoprotein

  2006cites this paper
• Synthesis of photoactivatable analogues of lysophosphatidic acid and covalent labeling of plasma proteins.

  2006cites this paper
• Identification of Residues Responsible for Ligand Recognition and Regioisomeric Selectivity of Lysophosphatidic Acid Receptors Expressed in Mammalian Cells*

  2005cites this paper
• Molecular defects in the ABCA1 pathway affect platelet function.

  2005cites this paper
• A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands.

  2004cites this paper
• Novel clusters of receptors for sphingosine‐1‐phosphate, sphingosylphosphorylcholine, and (lyso)‐phosphatidic acid: New receptors for “Old” ligands

  2004cites this paper
• Thrombogenic and atherogenic activities of lysophosphatidic acid

  2004cites this paper
• The alpha isoform of diacylglycerol kinase exhibits arachidonoyl specificity with alkylacylglycerol.

  2004cites this paper
• Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule Published, JLR Papers in Press, August 16, 2004. DOI 10.1194/jlr.D400010-JLR200

  2004cites this paper
• Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators

  2004cites this paper
• Lysophospholipids in development: Miles apart and edging in

  2004cites this paper
• Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation

  2004cites this paper
• The 2003 ASBMB-Avanti Award in Lipids Address: Applications of novel synthetic lipids to biological problems.

  2004cites this paper
• Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors.

  2004cites this paper
• Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Inhibit Platelet Activation Triggered by the Lipid Core of Atherosclerotic Plaques

  2003cites this paper
• Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family*

  2003cites this paper
• Molecular mechanisms of lysophosphatidic acid action.

  2003cites this paper